Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:1215-1222

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, J.
Right arrow Articles by Brown, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, J.
Right arrow Articles by Brown, R. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*High Blood Pressure
*Seniors' Health

(Hypertension. 1999;34:1215.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Influence of Age on Contractile Response to Insulin-Like Growth Factor 1 in Ventricular Myocytes From Spontaneously Hypertensive Rats

Jun Ren; LeQuishia Jefferson; James R. Sowers; Ricardo A. Brown

From the Department of Physiology (J.R.), University of North Dakota, Grand Forks, and the Departments of Physiology (L.J., R.A.B.) and Internal Medicine (J.R.S.), Wayne State University School of Medicine, Detroit, Mich.

Correspondence to Ricardo A. Brown, PhD, Department of Physiology, Wayne State University School of Medicine, 540 E Canfield Ave, Detroit, MI 48201. E-mail rbrown{at}med.wayne.edu

Abstract—Evidence suggests a pathophysiological role of insulin-like growth factor 1 (IGF-1) in hypertension. Cardiac function is altered with advanced age, similar to hypertension. Accordingly, the effects of IGF-1 on cardiac myocyte shortening and intracellular Ca2+ were evaluated in hypertension at different ages. Ventricular myocytes were isolated from Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR), aged 12 and 36 weeks. Mechanical and intracellular Ca2+ properties were examined by edge-detection and fluorescence microscopy. At 12 weeks, IGF-1 (1 to 500 ng/mL) increased peak twitch amplitude (PTA) and FFI changes ({Delta}FFI) in a dose-dependent manner in WKY myocytes, with maximal increases of 27.5% and 35.2%, respectively. However, IGF-1 failed to exert any action on PTA and {Delta}FFI in the age-matched SHR myocytes. Interestingly, at 36 weeks, IGF-1 failed to exert any response in WKY myocytes but depressed both PTA and {Delta}FFI in a dose-dependent manner in SHR myocytes, with maximal inhibitions of 40.5% and 16.1%, respectively. Myocytes from SHR or 36-week WKY were less sensitive to norepinephrine (1 µmol/L) and KCl (30 mmol/L). Pretreatment with nitric oxide synthase inhibitor N{omega}-nitro-L-arginine methyl ester (L-NAME, 100 µmol/L) did not alter the IGF-1–induced response in 12-week WKY myocytes but unmasked a positive action in 12-week SHR and 36-week WKY myocytes. L-NAME also significantly attenuated IGF-1–induced depression in 36-week SHR myocytes. In addition, the Ca2+ channel opener Bay K8644 (1 µmol/L) abolished IGF-1–induced cardiac depression in 36-week SHR myocytes. Collectively, these results suggest that the IGF-1–induced cardiac contractile response was reduced with advanced age as well as with hypertension. Alterations in nitric oxide and intracellular Ca2+ modulation may underlie, in part, the resistance to IGF-1 in hypertension and advanced age.


Key Words: insulin growth factor • hypertension, essential • aging • myocytes • calcium




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. Ren, J. Duan, K. K Hintz, and B. H Ren
High glucose induces cardiac insulin-like growth factor I resistance in ventricular myocytes: role of Akt and ERK activation
Cardiovasc Res, March 1, 2003; 57(3): 738 - 748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Duan, H.-Y. Zhang, S. D. Adkins, B. H. Ren, F. L. Norby, X. Zhang, J. N. Benoit, P. N. Epstein, and J. Ren
Impaired cardiac function and IGF-I response in myocytes from calmodulin-diabetic mice: role of Akt and RhoA
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E366 - E376.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Zhang, B. Molino, L. Yan, T. Haim, Y. Vaks, P. M. Scholz, and H. R. Weiss
Nitric oxide and cGMP protein kinase activity in aged ventricular myocytes
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2304 - H2309.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Galderisi, G. Vitale, G. Lupoli, M. Barbieri, G. Varricchio, C. Carella, O. de Divitiis, and G. Paolisso
Inverse Association Between Free Insulin-Like Growth Factor-1 and Isovolumic Relaxation in Arterial Systemic Hypertension
Hypertension, October 1, 2001; 38(4): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Vecchione, S. Colella, L. Fratta, M. T. Gentile, G. Selvetella, G. Frati, B. Trimarco, and G. Lembo
Impaired Insulin-Like Growth Factor I Vasorelaxant Effects in Hypertension
Hypertension, June 1, 2001; 37(6): 1480 - 1485.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Ren, J. R. Sowers, M. F. Walsh, and R. A. Brown
Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1708 - H1714.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Ren
Attenuated cardiac contractile responsiveness to insulin-like growth factor I in ventricular myocytes from biobreeding spontaneous diabetic rats
Cardiovasc Res, April 1, 2000; 46(1): 162 - 171.
[Abstract] [Full Text] [PDF]